Glycogen synthase kinase 3 phosphorylates RBL2/p130 during quiescence

Mol Cell Biol. 2004 Oct;24(20):8970-80. doi: 10.1128/MCB.24.20.8970-8980.2004.

Abstract

Phosphorylation of the retinoblastoma-related or pocket proteins RB1/pRb, RBL1/p107, and RBL2/p130 regulates cell cycle progression and exit. While all pocket proteins are phosphorylated by cyclin-dependent kinases (CDKs) during the G1/S-phase transition, p130 is also specifically phosphorylated in G0-arrested cells. We have previously identified several phosphorylated residues that match the consensus site for glycogen synthase kinase 3 (GSK3) in the G0 form of p130. Using small-molecule inhibitors of GSK3, site-specific mutants of p130, and phospho-specific antibodies, we demonstrate here that GSK3 phosphorylates p130 during G0. Phosphorylation of p130 by GSK3 contributes to the stability of p130 but does not affect its ability to interact with E2F4 or cyclins. Regulation of p130 by GSK3 provides a novel link between growth factor signaling and regulation of the cell cycle progression and exit.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Phospho-Specific / metabolism
  • Cell Cycle / physiology*
  • Cell Line
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 / metabolism*
  • Humans
  • Molecular Sequence Data
  • Phosphorylation
  • Protein Kinase Inhibitors / metabolism
  • Protein Structure, Tertiary
  • Proteins / genetics
  • Proteins / metabolism*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Retinoblastoma Protein / metabolism
  • Retinoblastoma-Like Protein p130
  • Signal Transduction / physiology

Substances

  • Antibodies, Phospho-Specific
  • Protein Kinase Inhibitors
  • Proteins
  • RBL2 protein, human
  • Recombinant Fusion Proteins
  • Retinoblastoma Protein
  • Retinoblastoma-Like Protein p130
  • Glycogen Synthase Kinase 3